2.27 -0.10 (-4.22%)

63.50% Fall from 52W High

6,153 XNAS Volume

XNAS 03 Apr, 2025 5:30 PM (EDT)



Insider Trading disclosures for Synaptogenix Inc

The latest disclosure was made by William S. Singer in Synaptogenix Inc where a trade of 800 Stock Option (Right to Buy) done was reported to US exchanges on April 8, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
William S. Singer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 800 800 - - Stock Option (Right to Buy)
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 800 800 - - Stock Option (Right to Buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 800 800 - - Stock Option (Right to Buy)
William S. Singer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2023 20,000 20,000 - - Stock Option (Right to Buy)
Daniel L. Alkon Director, President and CSO Sale of securities on an exchange or to another person at price $ 1.17 per share. 16 Dec 2022 19,688 35,546 - 1.2 23,072 Common Stock, par value $0.0001 per share
William S. Singer Director Sale of securities on an exchange or to another person at price $ 1.17 per share. 16 Dec 2022 27,000 33,000 - 1.2 31,641 Common Stock, par value $0.0001 per share
Bruce T. Bernstein Director Sale of securities on an exchange or to another person at price $ 1.17 per share. 16 Dec 2022 22,500 27,578 - 1.2 26,368 Common Stock, par value $0.0001 per share
Joshua Nathaniel Silverman Director Sale of securities on an exchange or to another person at price $ 1.17 per share. 16 Dec 2022 19,012 38,238 - 1.2 22,280 Common Stock, par value $0.0001 per share
Robert Weinstein Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.17 per share. 16 Dec 2022 27,000 33,198 - 1.2 31,641 Common Stock, par value $0.0001 per share
Alan J. Tuchman Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.17 per share. 16 Dec 2022 27,000 33,000 - 1.2 31,641 Common Stock, par value $0.0001 per share
Alan J. Tuchman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 68,850 68,850 - - Stock Option (Right to Buy)
Robert Weinstein Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 75,000 75,000 - - Stock Option (Right to Buy)
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 75,000 75,000 - - Stock Option (Right to Buy)
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 75,000 75,000 - - Stock Option (Right to Buy)
Daniel L. Alkon Director, See Remark Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 75,000 75,000 - - Stock Option (Right to Buy)
William S. Singer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 75,000 75,000 - - Stock Option (Right to Buy)
Alan J. Tuchman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2022 6,150 6,150 - - Stock Option (Right to Buy)
Robert Weinstein Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 60,000 60,198 - 0 Common Stock, par value $0.0001 per share
Joshua Nathaniel Silverman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 42,250 57,250 - 0 Common Stock, par value $0.0001 per share
Bruce T. Bernstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 50,000 50,078 - 0 Common Stock, par value $0.0001 per share
Daniel L. Alkon Director, President and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 43,750 55,234 - 0 Common Stock, par value $0.0001 per share
William S. Singer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 60,000 60,000 - 0 Common Stock, par value $0.0001 per share
Alan J. Tuchman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 60,000 60,000 - 0 Common Stock, par value $0.0001 per share
George Perry Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2021 40,000 40,000 - 0 Common Stock, par value $0.0001 per share
Joshua Nathaniel Silverman Director Purchase of securities on an exchange or from another person at price $ 8.30 per share. 14 Jun 2021 10,000 15,000 - 8.3 83,000 Common Stock, par value $0.0001 per share
Daniel L. Alkon Director, Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 8.26 per share. 14 Jun 2021 10,000 11,484 - 8.3 82,600 Common Stock, par value $0.0001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures